Available until September 1, 2024 - Podcast Online CME Education

Ashton C. Praska, PharmD describes tetracycline resistance mechanisms utilized by bacteria, identifies how Omadacycline/Eravacycline can overcome common tetracycline resistance mechanisms and identifies clinical scenarios where Omadacycline/Eravacycline could be considered for use.

Available until June 1, 2025 - Online CME Course

Join cardiac rehabilitation experts for a comprehensive review of program fundamentals including program structure and management, secondary cardiovascular disease prevention, and new trends in CR. Program topics will provide details to ensure patients receive the highest, most-up-to-date quality of care and achieve the best possible outcomes. These self-study materials will provide an overview for health professionals new to cardiac rehabilitation, or those wanting to update their existing program, based on the experience of Mayo Clinic, Rochester.

Available until October 31, 2025 - Online CME Course

Pharmacogenomics (PGx) is the study of how one’s genes may affect an individual's response to medication and is an emerging field within patient care. Mayo Clinic experts have created an online certificate program on how to integrate PGx into clinical practice for pharmacists, physicians, nurse practitioners, physician assistants, nurses & students. Learners enrolled in this course will enjoy over 16 hours of engaging content, including case studies and over 50 videos that can be reviewed at their own pace, anytime. Earn a certificate of completion and CME credit in the process.

Available until July 15, 2027 - Online CME Course

This online course consists of over 9 hours of self-paced, asynchronous education. The online content is based on current evidence-based, patient-centered standards for medical care in diabetes and includes recorded lectures and case studies. Content covers the following key topic areas: overview of diabetes, management and medications, special patient populations, complications, risk factor modifications and lifestyle management and prevention.

Available until February 1, 2026

Hearing loss is a commonly seen symptom in a primary care office practice, as is tinnitus and vertigo. Fortunately, they’re almost always due to a benign cause. However, these symptoms may represent something more ominous, an acoustic neuroma, also known as a vestibular schwannoma. It’s important to consider this diagnosis when we see them in our patients, as there is the potential for serious consequences to develop if this remains untreated. What type of hearing loss is associated with a vestibular schwannoma? What are the other associated symptoms? How do we go about evaluating these patients and how are they best treated? I’ll be asking these questions of our guests Michael J. Link, M.D., a neurosurgeon from the Department of Neurologic Surgery and Mathew L. Carlson, M.D., a head and neck surgeon from the Department of Otolaryngology, both at the Mayo Clinic in Rochester, Minnesota. Our topic for this podcast is vestibular schwannomas.

Available until September 1, 2024 - Podcast Online CME Education

Hailey Thompson, PharmD, reviews primary literature and shares updates on the role of monoclonal antibody therapies in the treatment of Alzheimer’s Disease.